February 4, 2013
 
 

Submit Your Abstract for SITC's Cancer Immunotherapy
Clinical Trials Workshop

Abstract submission is now open for SITC’s Cancer Immunotherapy Clinical Trials: Concepts and Challenges workshop, set to take place April 4-5, 2013 on the NIH Campus in Bethesda, MD. This two-day program will outline the current challenges posed by the development of therapeutic trials in immunotherapy. Several questions will be examined in greater detail, including preclinical testing requirements for clinical development, innovative clinical trial design, appropriate patient selection, end point determination, and developing combination therapies to improve long term disease management and survival. Accelerating anticancer agent development, validation and approvals will also be discussed. In addition to the invited faculty, there are several oral abstracts presenter slots available. SITC invites you to submit an abstract based on the problems and solutions identified in the abstract topic areas listed below.

Abstract Submission Highlights

• Abstract submission deadline: February 28, 2013 at 11:59 pm CT
• Cost to submit an abstract: FREE for both SITC members and nonmembers
• All submitted abstracts will be considered for oral presentation and printed in meeting materials

Abstract Topic Areas

• Early Vaccine Clinical Trial Development
• Early Immunemodulator Therapy Clinical Trial Development
• Immune Therapy In Combination
• Preclinical Development

For more information, to submit an abstract, or to register, please visit the SITC website.